CARE

Carter Bank and Trust

Financials · USD

CARE

Price

$24.4

+0.00%

Cap

$541M

Earnings

3/4 beat

30d Trend

CARE
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range96%
13.6124.86

Near 52-week highs — limited upside before resistance

Analyst consensus (4 analysts)+7% to target
1 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

Target range: $25$27 (consensus: $26)

Consensus: Buy

Earnings history

Q4 2025

BEAT

0.41 vs 0.33

Q3 2025

MISS

0.24 vs 0.32

Q2 2025

BEAT

0.41 vs 0.31

Q1 2025

BEAT

0.32 vs 0.3

VolatilityLow

Key macro factors

·

Central Banks Shifting to 'Higher for Longer' Rates Amid Inflation: As a bank, Carter Bankshares' profitability is highly sensitive to interest rate changes. Higher for longer rates can impact net interest margins by influencing the cost of deposits versus the yield on loans, and potentially affecting loan demand and credit quality.

·

Iran War Escalation Driving US Inflation: Increased inflation, as suggested by the 3.3% US inflation rate, can lead to higher operational costs for the bank and may impact consumer spending and borrowing behavior within its service areas. It can also influence the Federal Reserve's monetary policy decisions, which directly affect interest rates.

·

Q1 2026 Earnings Season for Major US Banks: The overall performance and outlook from larger US banks during the Q1 2026 earnings season can set sentiment for the entire financial sector, including regional banks like Carter Bankshares. Positive or negative trends reported by major players could impact investor perception and CARE's stock performance.

Carter Bankshares, Inc. operates as the bank holding company for Carter Bank & Trust, providing various retail and commercial banking products and insurance services in the United States.

Next earnings:2026-04-23

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

Carter Bank and Trust (CARE) — Brain47 AI Score 58/100 | Analysis